Apyx medical corporation to release second quarter of fiscal year 2022 financial results on august 11, 2022

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), a maker of medical devices and supplies and the developer of helium plasma technology, marketed and sold as renuvion® and j-plasma® in surgical markets, today announced that financial results for the second quarter of fiscal year 2022 will be released after the market closes on thursday, august 11th. management will host a conference call at 5:00 p.m. eastern time on august 11th to discuss the results of
APYX Ratings Summary
APYX Quant Ranking